Gefitinib and interstitial lung disease Patient Reports February 12, 2012

Gefitinib Side Effects Report #4673630-X
Gefitinib side effect was reported by a Health Professional from on May 19, 2005. Male patient, 71 years of age, was diagnosed with squamous cell carcinoma and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: circulatory collapse, interstitial lung disease. Gefitinib dosage: unknown. Patient was hospitalized. Patient died.

Gefitinib Side Effects Report #4569569-0
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 24, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, interstitial lung disease, lung infection, lymphangiosis carcinomatosa, malignant neoplasm progression, respiratory distress, respiratory failure. Gefitinib dosage: 250 MG DAILY. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient died.

Gefitinib Side Effects Report #4576177-4
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 24, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, lung infection, pyrexia, respiratory distress, respiratory failure. Gefitinib dosage: 250 MG DAILY. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient died.

Gefitinib Side Effects Report #5267862-X
Gefitinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2005. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary fibrosis . Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DOCETAXEL. Patient died.


Gefitinib Side Effects Report #5267547-X
Gefitinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2005. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary fibrosis . Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DOCETAXEL. Patient died.

Gefitinib Side Effects Report #5876795-7
Gefitinib side effect was reported by a Health Professional from JAPAN on Sept 09, 2008. Male patient, 71 years of age, was diagnosed with lung adenocarcinoma and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gefitinib dosage: unknown. Patient died.

Gefitinib Side Effects Report #5876797-0
Gefitinib side effect was reported by a Health Professional from JAPAN on Sept 09, 2008. Male patient, 70 years of age, was diagnosed with lung adenocarcinoma and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gefitinib dosage: unknown. Patient died.